ducovest

HMMJ-U:CA:TSX-Global X Marijuana Life Sciences Index ETF (USD)

ETF | Others |

Last Closing

CAD 5.03

Change

+0.03 (+0.60)%

Market Cap

CAD 0.09B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: USD

Country : Canada

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

N/A

 CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

 CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

 CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

N/A

 CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

N/A

 CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

 CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

 CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

 CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

N/A

 CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

 CAD 2.78B

ETFs Containing HMMJ-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -19.52% 3% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.52% 3% F 6% D-
Trailing 12 Months  
Capital Gain -39.83% 2% F 4% F
Dividend Return 0.92% 28% F 17% F
Total Return -38.92% 1% F 4% F
Trailing 5 Years  
Capital Gain -12.67% 10% F 18% F
Dividend Return 11.75% 38% F 25% F
Total Return -0.92% 13% F 18% F
Average Annual (5 Year Horizon)  
Capital Gain 13.07% 90% A- 80% B-
Dividend Return 13.24% 90% A- 75% C
Total Return 0.17% 22% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 56.56% 4% F 14% F
Risk Adjusted Return 23.42% 33% F 39% F
Market Capitalization 0.09B 61% D- 33% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.